trending Market Intelligence /marketintelligence/en/news-insights/trending/ccx31n5q25rnwj2oayeypg2 content esgSubNav
In This List

Merck & Co. to create 350 jobs at new manufacturing facility in Ireland

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Merck & Co. to create 350 jobs at new manufacturing facility in Ireland

Merck & Co. Inc. plans to create 350 new jobs by building a biologics manufacturing facility at its Swords site near Dublin, Ireland, FiercePharma reported Feb. 14.

Biologics are large molecules derived from natural sources, such as microorganisms or plant or animal cells.

The company plans to use the new facility to produce its blockbuster cancer drug Keytruda.

Merck expects the plant to be ready by 2021 and start producing commercial products the next year, the news outlet reported.